Tagged Content
Tags > Medication Updates
Year: Medication:  Antipsychotics Belsomra Cymbalta Effexor Farxiga Geodon Hysingla ER Lunesta Methylphenidate Naloxone/Evzio Naltrexone Olanzapine/Zyprexa Opioids Tanzeum Targiniq ER Tramadol Ziprasidone Zolpidem Zyprexa General Resources:   DEA Pharmacists' Manual FDA Medication Updates NIMH Mental Health Medications Guide         2015       Extended-Release Injectable Naltrexone New SAMHSA guidance on the use of medication assisted treatment with extended-release injectable naltrexone for the treatment of opioid use disorder.                 2014   Ziprasidone: FDA Warning FDA reporting mental health drug ziprasidone (Geodon) associated with rare but potentially fatal skin reactions. FDA approves Hysingla ER This extended-release, single-entity hydrocodone product has abuse-deterrent properties   Recall of Effexor issued by Manufacturer Sun Pharmaceutical Industries Ltd.



View all tags
View RSS XML